After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president, Human Health International, and Dr. Marjorie Green, senior vice president and ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Illumina Complete Long Read Prep, Human. Compatible with sequencing systems for high ... partnered with Molecular Health to integrate their NGS capabilities and to extend genomic profiling.

Public health leaders warned of an incoming fiscal cliff during the pandemic, when the federal government provided historic cash infusions to states, most of which have expired.

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

This study provides a comprehensive look at the different types of antibody drugs, including human, humanized ... This means ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Merck & Company ( (MRK) ) has released its Q3 earnings. Here is a breakdown of the information Merck & Company presented to its ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Veterinary ...